Endo Divests Non-Core Business Lines From Litha Healthcare - Quick Facts

(RTTNews) - Endo International plc (ENDP, ENL.TO) announced the strategic divestiture of a portfolio of device, vaccine and other non-core products from its international subsidiary in South Africa, Litha Healthcare Group, to a consortium comprised of Westrate Trade and Invest Proprietary Limited and Immunotek (Pty) Limited.

The company said the transaction is not expected to have a material impact on its financial results in the current year.

"The transaction further reinforces our commitment to grow and streamline our international business to align with Endo's focus on becoming a leading global specialty pharmaceutical business," said Rajiv De Silva, President and CEO of Endo.